Consideration of Side Effects in Extended Endocrine Therapy Decision Making

Consideration of Side Effects in Extended Endocrine Therapy Decision Making

Guideline Updates for Extended Endocrine Therapy Decision-Making in HR+, Early-Stage Breast CancerПодробнее

Guideline Updates for Extended Endocrine Therapy Decision-Making in HR+, Early-Stage Breast Cancer

Fast Facts: The side effects of endocrine treatmentПодробнее

Fast Facts: The side effects of endocrine treatment

JADPRO Live 2023 - Standardizing Extended Endocrine Therapy Decision-MakingПодробнее

JADPRO Live 2023 - Standardizing Extended Endocrine Therapy Decision-Making

Rounds with the Investigators: Compelling Teaching Cases Focused on the Role of Endocrine-Based T...Подробнее

Rounds with the Investigators: Compelling Teaching Cases Focused on the Role of Endocrine-Based T...

Guideline Updates for Extended Endocrine Therapy Decision-Making in HR+, Early-Stage Breast CancerПодробнее

Guideline Updates for Extended Endocrine Therapy Decision-Making in HR+, Early-Stage Breast Cancer

Role of Advanced Practitioners in Extended Endocrine Therapy Decision-Making (or BCI)Подробнее

Role of Advanced Practitioners in Extended Endocrine Therapy Decision-Making (or BCI)

The Role of BCI in Extended Endocrine Therapy Decision MakingПодробнее

The Role of BCI in Extended Endocrine Therapy Decision Making

Utilizing the Appropriate Tool for Extended Endocrine Therapy Decision-Making: BCI vs Oncotype DxПодробнее

Utilizing the Appropriate Tool for Extended Endocrine Therapy Decision-Making: BCI vs Oncotype Dx

Updates in Extended Endocrine Therapy for HR+ Breast Cancer | ASCO21 & National Practice GuidelinesПодробнее

Updates in Extended Endocrine Therapy for HR+ Breast Cancer | ASCO21 & National Practice Guidelines

How did the side effects of anti-estrogen therapy impact your daily life?Подробнее

How did the side effects of anti-estrogen therapy impact your daily life?

What Genomic Assay is Best Suited for the Extended Endocrine Therapy Decision?Подробнее

What Genomic Assay is Best Suited for the Extended Endocrine Therapy Decision?

Extended adjuvant AI not advised for HPBC after 5+ yrs of sequential endocrine therapyПодробнее

Extended adjuvant AI not advised for HPBC after 5+ yrs of sequential endocrine therapy

Endocrine Treatment in Breast CancerПодробнее

Endocrine Treatment in Breast Cancer

Are You Making Optimal Extended Endocrine Decisions with Your Patients?Подробнее

Are You Making Optimal Extended Endocrine Decisions with Your Patients?

Discussing Extended Endocrine Therapy With PatientsПодробнее

Discussing Extended Endocrine Therapy With Patients

The role of SOFT and TEXT in treatment decision making for patients with breast cancerПодробнее

The role of SOFT and TEXT in treatment decision making for patients with breast cancer

Determining Endocrine Therapy for Premenopausal Breast Cancer Patients: Practical ConsiderationsПодробнее

Determining Endocrine Therapy for Premenopausal Breast Cancer Patients: Practical Considerations

Breast Cancer: Extended Adjuvant Endocrine TherapyПодробнее

Breast Cancer: Extended Adjuvant Endocrine Therapy

Switching Hormonal Therapies for Breast Cancer: All You Need to KnowПодробнее

Switching Hormonal Therapies for Breast Cancer: All You Need to Know